In contrast, there was no significant correlation between the IDO+ SI in PTs and other clinical and pathological indexes, such as age, menstrual status, tumor diameter, pathological type, histological grade, and expression of ER, PR, or Her2. This evidence concerns the gene ERBB2 and neoplasm.